In Cancer Therapy China we have successfully treated patients suffering from a number of advanced cancers with a novel combination of therapies including the most cutting-edge AAV-DC-CTLTM Tumor Cell Targeting Therapy(ACLTTM), Gene Therapy Drug (Gendicine), Immunotherapy (CIK / DC-CIK biotherapy), Cancer Stem Cell Targeted Treatment, Gentle Chemotherapy, Traditional Chinese Medicine (Herb), powerful Antiangiogenosis Drug (Endostar), and HIFU non-invasive or Croysurgery minimal invasive system if suitable for local control of tumor like pancreatic cancer and liver cancer. The combination treatment has very little to no side-effects. This combination treatment has provided very encouraging results with more than 65% effective rate for liver, lung, pancreatic, colorectal, ovarian, and breast cancer patients even with metastases. The patients came
from different countries including Turkey, Holland, Australia, US, Canada, Germany, Britain and Singapore and many had already failed to respond to varieties of chemotherapy regimens. Our organization has the leading centers for treatment of other cancers.
Professor Yong Liu MD PHD - Deputy Director and Professor in Rockefeller Cancer Institute of gene therapy and immunotherapy Center, University of Arkansas, USA
During the research work in the US for more than 10 years, Professor Liu has been awarded with a number of research funding from China and the US, including the National Natural Science Foundation of China, research grant of the National Institutes of Health (NIH) and the National Science Foundation fund in the US, which was about 400 thousands US dollars research funding annually. Professor LIU has published over 60 scientific articles with accumulated impact factor over 200 scores, 5 US and international patents and outstanding awards from NIH, ASCO and oncology associations in the US. Professor LIU is currently a committee member of ASCO in immunotherapy and the editorial member or expert reviewer of a number of basic science and clinical research periodical journals related to oncology, immunology, virus and molecular biology.
| || |
| || ||Dr. Shewen Luo (Sherman) MD.PHD, the People's Armed Police General Hospital (Wujing Hosptial), Director of International Cancer Treatment Center |
He is the Chairman of international medical department at WJGH. His field is combined to Traditional Chinese medicine and Western medicine.He is the secretary-general of senile disease branch at association of traditional Chinese medicine in China.The deputy director of traditional Chinese medicine institution at gerontology association in China; The executive member of the council at pulmonary disease committee in the world association of Chinese medicine. He is also member of Beijing Chinese medicine academic society and gerontology committee in the Chinese people’s armed police force.He has experience at diabetes, cerebrovascular and cardiovascular disease; chronic cough, asthma syndrome, thirst, constipation and incurable insomnia and specializes in traditional Chinese medicine cancer treatment. As well as, patients psychological counseling.
He has own new ideas about anti-aging health care and rehabilitation care.He has published more than 30 academic papers and 4 academic books.It was a great contribution at the first prize in the association of Chinese medicine science and technology award; the third prize in the Beijing science and technology award and another two prizes in WJ science and technology award.
| || |
Dr. Danmei Zhang (May) MD PHD the People's Armed Police General Hospital (Wujin Hosptial)
She is the Chief physician at WJ International Medical Center. Graduated from Second Medical College of PLA in Shanghai, China. As a postdoctoral fellow, studied at Baylor College of Medicine in Houston, USA; at Louisiana University Medical Center in New Orleans USA; at New York hospital, it belongs to Weill Medical College, Cornell University in New York, USA.Specializes in geriatrics, respiratory diseases, lung cancer, internal medicine, health management, fiber bronchoscopic diagnosis and treatment, and proficient in molecular biological therapy. Technology. She was a chairman of respiratory department and #2 VIP department. She also was involved in Cardiology Department and emergency department. Now, she is a senile disease physician, to get in touch with general medicine problem.
| || |
| || ||Prof. Xiao WenHua, The 304 Hosptial, Director of Oncology |
Graduated from one of the most famous HuaXi Southwest Medical University. Also, engaged with the Third Military Hospital Medical University for clinical research in cancer. Professor Xiao, is also the Director of the First affiliated hospital of Chinese PLA General Hospital Oncology. Cancer members of the Special Committee of the Army; Member of Anti-cancer Association in Beijing; Aged cancer of Chinese anti-cancer Association Executive Committee members of the IPCC. With the best knowledge of common tumors, such as lung, liver, breast, gastrointestinal, renal cancer. Dr. Xiao, also has extensive experiences with stem cell transplantation for malignant tumors, cancer chemotherapy drug sensitivity test of individual guidance, cancer vaccines and immunotherapy of dendritic cell tumor and tumor-targeting therapy.
| || || || |
| || ||Prof. Cui Zheng |
The Chief Scientist of LIFE cancer treatment. And, Professor Cui is also the chief scientist of Wake Forest University and Pathological cancer institute.
| || || || |
Qi Niu MD, The 309 Hospital, Associate Professor of Medicine
Dr. Niu studied on breast cancer diagnosis and treatment as well as
cancer biology in Harvard University for 4 years. He has plentiful
experiences in diagnosing and treating breast, pancreas, colorectal,
liver and lung cancers. Dr. Niu has made big successes with his
innovative approaches targeting at cancer stem cells in improving the
treatment effects of pancreas, breast, and colorectal cancer patients
from different countries including Turkey, Holland, Australia, US,
Canada, Germany, Britain and Singapore who failed to reply varieties
of chemotherapy regimens in their own countries. Meanwhile, he is one
of the top oncologists in the world in clinical anti-cancer gene therapy.
| || || |
| || ||Yunhua Bao, Professor of Medicine |
Dr. Bao has clinical experiences in treating various commonly seen cancers
for more than 40 years. He is a current consultant oncologist for Central
Chinese Communist Party Committee members. He is especially experienced
in the combination treatment of lung cancer.
| || ||Jingzhi Guan MD, Senior Attending Doctor|
Dr. Guan received her MD degree in Japan. Her clinical practice focuses on the
reversal of chemotherapy resistance in breast cancer treatment. She is very
experienced in diagnosis and treatment of breast cancer, especially in the field of
breast cancer hormonal therapy
| || |
Guokun Ao, Master of Medicine, Associate Professor of Interventional
Dr. Ao has 20 years experiences in radiology and interventional oncology
including working experiences in Freiburg University School of Medicine in
German. His clinical interest is in interventional treatment of liver, lung,
kidney, and colorectal cancer.
| || ||Jin Lei, Associate Professor of Chinese Traditional Medicine|
Dr. Lei has more than 20 years of experiences in treating cancer with Chinese
traditional medicine practice especially in relieving the side effects of